Getinge reported mixed Q2 numbers – top-line and order beat, and bottom-line miss. The order book was driven by the life science business and the EMEA region, while sales were driven by life science and APAC. Margin contraction, on the other hand, to a large extent, was a function of a higher sales contribution from emerging markets and capital goods. Given that the order book development was strong but driven again by emerging markets, we expect margin pressure to persist.
18 Jul 2018
Life sciences and EMEA boost order book; revenue guidance upgraded
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Life sciences and EMEA boost order book; revenue guidance upgraded
Getinge AB Class B (GTN:FRA) | 0 0 0.9% | Mkt Cap: 25,911m
- Published:
18 Jul 2018 -
Author:
Kamla Singh -
Pages:
3
Getinge reported mixed Q2 numbers – top-line and order beat, and bottom-line miss. The order book was driven by the life science business and the EMEA region, while sales were driven by life science and APAC. Margin contraction, on the other hand, to a large extent, was a function of a higher sales contribution from emerging markets and capital goods. Given that the order book development was strong but driven again by emerging markets, we expect margin pressure to persist.